- Filed
- Nov 6, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Oct 30, 2024 | 30.12M sh |
| Cash And Equivalents | Q3 2024 · Sep 28, 2024 | $181M |
| Cash And Equivalents | Q3 2024 · Dec 30, 2023 | $381M |
| Current Liabilities | Q3 2024 · Sep 28, 2024 | $1.67B |
| Current Liabilities | Q3 2024 · Dec 30, 2023 | $1.7B |
| Total Liabilities | Q3 2024 · Sep 28, 2024 | $2.84B |
| Total Liabilities | Q3 2024 · Dec 30, 2023 | $2.79B |
| Current Assets | Q3 2024 · Sep 28, 2024 | $1.54B |
| Current Assets | Q3 2024 · Dec 30, 2023 | $1.74B |
| Total Assets | Q3 2024 · Sep 28, 2024 | $3.69B |
| Total Assets | Q3 2024 · Dec 30, 2023 | $3.89B |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 39M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 40M sh |
| Stock Repurchased | Q3 2024 · Sep 30, 2023 | $264M |
| Capex restated | Q3 2024 · Sep 30, 2023 | $56M |
| Operating Cash Flow restated | Q3 2024 · Sep 30, 2023 | $262M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $1.16B |
| Stockholders Equity | Q3 2024 · Jul 1, 2023 | $1.16B |
| Stockholders Equity | Q3 2024 · Apr 1, 2023 | $1.15B |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $1.29B |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $1.79 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $4.38 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $1.83 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $4.52 |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $360M |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $1.07B |
| Net Income | Q3 2024 · Sep 30, 2023 | $70M |
| Net Income | Q3 2024 · Sep 30, 2023 | $176M |
| Net Income | Q3 2024 · Jul 1, 2023 | $34M |
| Net Income | Q3 2024 · Apr 1, 2023 | $72M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | $108M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | $279M |
| Gross Profit restated | Q3 2024 · Sep 30, 2023 | $472M |
| Gross Profit restated | Q3 2024 · Sep 30, 2023 | $1.37B |
| Cost Of Revenue | Q3 2024 · Sep 30, 2023 | $1.54B |
| Cost Of Revenue restated | Q3 2024 · Sep 30, 2023 | $4.65B |
| Revenue restated | Q3 2024 · Sep 30, 2023 | $2.01B |
| Revenue restated | Q3 2024 · Sep 30, 2023 | $6.02B |